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ABSTRACT
The review of QSARs for genotoxicity and carcinogenicity was performed in a broad sense, 
considering both models available in software tools and models that are published in the 
literature. The review considered the potential applicability of diverse models to pesticides as 
well as to other types of regulated chemicals and pharmaceuticals. The availability of models 
and information on their applicability is summarised in tables, and a range of illustrative or 
informative examples are described in more detail in the text. In many cases, promising 
models were identified but they are still at the research stage. For routine application in a 
regulatory setting, further efforts will be needed to explore the applicability of such models 
for specific purposes, and to implement them in a practically useful form (i.e. user-friendly 
software). It is also noted that a range of software tools are research tools suitable for model 
development, and these require more specialised expertise than other tools that are aimed 
primarily at end-users such as risk assessors. It is concluded that the most useful models are 
those which are implemented in software tools and associated with transparent documentation 
on the model development and validation process. However, it is emphasised that the 
assessment of model predictions requires a reasonable amount of QSAR knowledge, even if it 
is not necessary to be a QSAR practitioner.
LIST OF ABBREVIATIONS
AhR Aryl Hydrocarbon Receptor
CHL Chinese Hamster Lung cells
CHO Chinese Hamster Ovary cells
DfW Derek for Windows (Lhasa Ltd)
DNA Deoxyribonucleic acid
ECHA European Chemicals Agency
EU European Union
GHS Globally Harmonized System of Classification and Labelling of Chemicals
JRC Joint Research Centre
NCCT National Center for Computational Toxicology
NTP National Toxicology Program
OECD Organisation for Economic Cooperation and Development
QMRF QSAR Model Reporting Format
QSAR Quantitative Structure-Activity Relationship
SAR Structure-Activity Relationship
SAs Structural Alerts
SCE Sister Chromatid Exchange
TTC Threshold of Toxicological Concern
UDS Unscheduled DNA synthesis
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11. Introduction
To date, hundreds of (Q)SAR models have been published in the literature for predicting genotoxicity 
and carcinogenicity. The most commonly modelled endpoint for genotoxicity has been Ames test 
mutagenicity, whereas carcinogenicity models have focused mostly on the rodent bioassay. In this 
report describes the background biology, the various methodologies used, and summarises some of the 
key conclusions from the extensive literature concerning the predictivity and applicability of existing 
models.
2. Background biology
Mutagenicity refers to the induction of permanent transmissible changes in the amount or structure of 
the genetic material in cells or organisms. These changes may involve a single gene (point mutations), 
a block of genes or entire chromosomes (structural or numerical chromosome aberrations). 
Genotoxicity is a broader term and refers to processes that alter the structure, information content or 
segregation of DNA and which are not necessarily associated with mutagenicity. Such processes 
include unscheduled DNA synthesis (UDS), sister chromatid exchange (SCE), DNA strandbreaks, 
DNA adduct formation, and mitotic recombination. In many cases, genotoxicity may lead to cancer. 
Thus, genotoxicity testing is performed to assess the potential of substances to induce genotoxic 
effects which may cause heritable damage or lead to cancer in humans. A summary of different types 
of genotoxicity test is given in Table 1.
Chemicals are defined as carcinogenic if they induce tumours, increase tumour incidence and/or 
malignancy or shorten the time to tumour occurrence (ECHA, 2008). Traditionally, carcinogens have 
been identified from epidemiological studies or from animal experiments. Carcinogenic chemicals 
have conventionally been divided into two broad categories based of the presumed mode of action: 
genotoxic or non-genotoxic. Genotoxic carcinogens cause damage by interacting directly with DNA –
many known mutagens are in this category. In contrast, non-genotoxic carcinogens cause “epigenetic” 
changes, i.e. effects that do not involve alterations in DNA but that may influence the carcinogenic 
process. The mechanistic understanding of the carcinogenic process differs considerably between the 
two modes of action. The distinction is not absolute – chemicals can be carcinogenic by both models 
of action.
A unifying scientific theory for the mode of action of epigenetic carcinogens is still missing, because 
they act through a wide variety of different and specific mechanisms. For this reason, QSARs for 
epigenetic carcinogenicity are still in an early stage of development. A number of structural alerts 
(SAs) and characteristics of several types of non-genotoxic carcinogens have been summarised and 
(Woo & Lai, 2003). Recognised mechanisms of non-genotoxic carcinogenicity include peroxisome 
proliferation, aryl hydrocarbon receptor (AhR) binding, inhibition of gap junctional intercellular 
communication, oxidative stress, alteration of DNA methylation, endocrine disruption and renerative 
cell proliferation (Woo & Lai, 2003).
In contrast, in the case of genotoxic carcinogens, the electrophilic theory was introduced more than 25 
years ago by James and Elizabeth Miller (Miller & Miller, 1981) who also led the way for the use of 
(Q)SAR in the prediction of genotoxicity and carcinogenicity. In general, genotoxic carcinogens have 
the unifying feature that they are either electrophiles or can be activated to electrophilic reactive 
intermediates (pro-electrophiles). The electrophilic theory of genotoxic carcinogenicity has led to two 
main (Q)SAR approaches for modelling  genotoxic chemicals: a) to identify the electrophilic 
functional groups or substructures, i.e. to develop SAR models based on structural alerts (SAs); and b) 
to find molecular descriptors which can be quantitatively related to the activity of the chemicals, i.e. to 
develop QSARs. Most studies have provided qualitative models (SARs), which provide a “coarse-
grain” approach for the identification of genotoxic potential. In addition, although more challenging, 
2numerous studies have attempted to develop quantitative models (QSARs), which provide a more 
precise means of assessing genotoxicity and carcinogenicity, mainly for congeneric sets of chemicals.
3.  Regulatory classification of mutagens and carcinogens
A summary of the former EU and new GHS criteria for classifying substances on the basis of 
mutagenicity and carcinogenicity is given in Table 2. These schemes classify substances into different 
levels of concern based on the strength and weight of available evidence. Expertise in ergaultory 
toxicology is required to apply the classification criteria in a consistent manner.
4. Databases
A number of web-based databases provide access to experimental data for mutagenicity 
carcinogenicity, and are thus useful for (Q)SAR development and assessment. Until recently, public 
toxicity databases were constructed primarily as “look-up-tables” of existing data, and most often did 
not contain chemical structures. However, modern technologies are now providing powerful tools to 
create new types of searchable databases, providing an effective means of linking toxicity with 
chemical structure. Some databases only allow information to be retrieved chemical-by-chemical but 
others provide the possibility to download an entire database. Several reviews have surveyed the status 
of public toxicity databases (Richard &  Williams 2003; Benigni et al., 2008a). In this section, a short 
explanation is given of the main databases, and a summary is presented in Table 3.
CPDB: The Carcinogenic Potency Database (CPDB) (http://potency.berkeley.edu/cpdb.html) provides 
a unique resource of the results of 6540 chronic, long-term animal cancer tests on 1547 chemicals. The 
CPDB provides easy access to the bioassay literature, with qualitative and quantitative analyses of 
both positive and negative experiments that have been published over the past 50 years in the general 
literature through 2001 and by the National Cancer Institute/National Toxicology Program through 
2004. The CPDB is downloadable in pdf, xls and txt formats, and is searchable by chemical name, 
CAS number, or author.
Danish QSAR database: The Danish EPA has developed a (Q)SAR database as a free source of 
predicted toxicities (not experimental data) for over 166,000 chemicals. For information on 
genotoxicity, the database contains predictions for various types of Ames test as well as  a range of in 
vitro endpoints: chromosomal aberrations (CHO and CHL cells), gene mutation assays (mouse 
lymphoma/tk, CHO/hprt) and Unscheduled DNA Synthesis (UDS) in rat hepatocytes. A range of in 
vivo models are also included (Drosophila SLRL, mouse micronucleus, rodent dominant lethal assay, 
mouse Sister Chromatid Exchange (SCE) in bone marrow and mouse Comet assay). All these models 
were derived using the MULTICASE software. For information on carcinogenicity, the database 
includes (in addition to the genotoxicity models), eight MULTICASE FDA cancer models, rodent 
carcinogenic potency, hepatospecificity, oestrogenicity and aryl 33 hydrocarbon (AH) receptor 
binding. The Danish QSAR database can be freely accessed over the internet from the JRC website 
(http://ecbqsar.jrc.it/). The database includes a flexible system for chemical structure and parameter 
searching. This database should be used with caution, since the data are not experimental data but 
predictions, many of which will not resultfrom use of the more recent models.
DSSTOX: Both the CPDB and the online NTP database have been “chemically-indexed” in the 
DSSTox (Distributed Structure-searchableToxicity) database (http://www.epa.gov/ncct/dsstox), 
developed by US EPA’s National Center for Computational Toxicology (NCCT). DSSTOX 
emphasises quality procedures for accurate and consistent chemical structure annotation of 
toxicological experiments. Chemical structures and summary mutagenicity and carcinogenicity data 
have been published for the entire CPDB inventory (www.epa.gov/ncct/dsstox/sdf_cpdbas.html), 
along with the URL address locating the specific chemical data webpage on the CPDB website 
provided for each indexed chemical substance. Chemical structures and indicators of data availability 
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four main NTP study areas (developmental, immunological, genetox, and chronic cancer bioassays).
ECHA CHEM: Information on susbtances evaluated under REACH are provided by ECHA CHEM, 
which is hosted by the European Chemicals Agency  (ECHA) 
(http://echa.europa.eu/chem_data_en.asp).  
ESIS: The European chemical Substances Information System (ESIS) is a freely accessible data via 
the JRC ex-ECB website (http://ecb.jrc.ec.europa.eu/esis/) providing information on chemicals related 
to: EINECS (European Inventory of Existing Commercial chemical Substances); ELINCS (European 
List of Notified Chemical Substances); NLP (No-Longer Polymers); the Biocidal Products Directive 
(BPD) active substances listed in Annex I or IA of Directive 98/8/EC or listed in the so-called list of 
“non-inclusions”; PBT (Persistent, Bioaccumulative, and Toxic) or vPvB (very Persistent and very 
Bioaccumulative) assessments of Existing Substances; Classification and Labelling (C&L), the Export 
and Import of Dangerous Chemicals listed in Annex I of Regulation (EC) No 689/2008; High 
Production Volume Chemicals (HPVCs) and Low Production Volume Chemicals (LPVCs), including 
EU Producers/Importers lists; IUCLID Chemical Data Sheets; EU Priority Lists and EU Risk 
Assessments produced under the Existing Substances Regulation (ESR).
EXCHEM: This database (http://dra4.nihs.go.jp/mhlw_data/jsp/SearchPageENG.jsp) was developed 
by the Chemicals Investigation Promoting Council, Japan and was supervised by Office of Chemicals 
Safety Evaluation and Licensing Bureau Pharmaceutical and Food Safety Bureau Ministry of Health, 
Labour and Welfare, Japan. EXCHEM contains data for Ames mutagenicity, chromosomal aberrations 
and mouse micronucleus assays for more than 250 HPV chemicals. Most of the information is in 
Japanese but there is also information in English. The database is searchable by CAS number and 
name.
GAP: The Genetic Activity Profile Database was initially developed by US EPA and IARC, and now 
by ILS (http://www.ils-inc.com). Data on approx 300 chemicals were compiled from volumes 1-50 of 
the IARC Monographs and on 115 compounds identified as Superfund Priority Substances. The data 
(qualitative and quantitative) are displayed as graphic profiles and data tables for up to 200 short-term 
assays that range from bacterial tests to human studies in vivo. The latest version was produced in 
2000 (GAP2000). A CD rom is available on request from ILS. 
IARC: The International Agency for Research on cancer (IARC) website provides access to the IARC 
Monographs on the Evaluation of Carcinogenic Risks to Humans 
(http://monographs.iarc.fr/index.php). The IARC Monographs have reviewed more than 900 chemcials 
and have identified more than 400 known, probable and possible carcinogens. The monographs are 
searchable by key word, CAS number, synonym or chemical name.
ISSCAN: This database (http://www.iss.it/ampp/dati/cont.php?id=233&lang=1&tipo=7), developed 
by the Istituto Superiore di Sanità (Rome, Italy), contains information on more than 1150 chemical 
compounds tested with the long-term carcinogenicity bioassay on rodents (rat, mouse). Historically, 
this database was developed to support the development of (Q)SAR models for chemical 
carcinogenicity. ISSCAN is downloadable in pdf, xls and sdf formats, and is searchable by chemical 
name and CAS number.
NTP: The US National Toxicology Program (NTP) (http://ntp.niehs.nih.gov) provides access to 
publicly available data from more than 500 two-year, two species, toxicology and carcinogenesis 
studies collected by the NTP and its predecessor, the National Cancer Institute's Carcinogenesis 
Testing Program. The NTP database also contains results relating to approximately 300 toxicity studies 
from shorter duration tests and from more than 2000 genetic toxicity studies, including both in vitro 
and in vivo tests. In addition, test data from the immunotoxicity, developmental toxicity and 
reproductive toxicity studies are continually being added to this database. The data can be accessed as 
technical reports; the user can browse them directly, make searches (by chemical name or CAS 
number, for example), or download the reports in pdf form. 
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partnership with EPA's Office of Pesticide Programs (OPP), to store data from in vivo animal toxicity 
studies. The original aim was to populate ToxRefDB with pesticide registration toxicity data that has 
been historically stored as hard-copy and scanned documents by OPP. ToxRefDB currently includes 
chronic, cancer, sub-chronic, developmental, and reproductive studies on 330 chemicals, many of 
which are pesticide active ingredients. ToxRefDB is downloadable in xls format but without structural 
information.
TOXNET: The TOXNET database of the US National Library of Medicine (NLM) 
(http://toxnet.nlm.nih.gov) is a cluster of different databases, collecting information on toxicology, 
hazardous chemicals, environmental health, and toxic releases. From the website, it is possible to 
search within and across the databases by several identifiers, such as chemical name, CAS number, 
molecular formula, classification code, locator code, and structure or substructure. Among the 
TOXNET databases, the Chemical Carcinogenesis Research Information System (CCRIS) and the 
GENE-TOX databases deal specifically with mutagenicity and carcinogenicity data. CCRIS contains 
over 9000 chemical records with animal carcinogenicity, mutagenicity, tumour promotion, and tumor 
inhibition test results provided by the National Cancer Institute (NCI). Test results have been reviewed 
by experts in carcinogenesis and mutagenesis. GENE-TOX was developed by the US EPA and 
contains genetic toxicology (mutagenicity) test data, resulting from expert peer review of the open 
scientific literature, on over 3000 chemicals.
5.  Structure-activity relationships for non-congeneric chemicals
One of the simplest and best known approaches to predict genotoxicity and carcinogenicity for 
structurally diverse chemicals is based on the use of SAs, sometimes accompanied by modulating 
factors. This section traces the development of the main SA-based approaches.
The first list SAs for mutagenicity was proposed by Ashby (Ashby 1985), who subsequently extended 
the lists with additional SAs as well as some detoxifying functionalities (Ashby and Tennant 1988). 
The resulting 19 SAs are referred to collectively as the Ashby poly-carcinogen model, often 
represented by a fictitious chemical structure containing all of the alerts (Figure 1).
Bailey et al. (Bailey et al. 2005) generated a list of 33 SAs for regulatory use in the US FDA. This list 
was based on the Ashby alerts and on a list compiled by Munro et al. (Munro et al., 1996).  
Kazius et al. (Kazius et al. 2005) produced another list of SAs by using a combination of data mining 
and expert knowledge. This list contains 29 SAs accompanied with detoxifying fragments and is 
reported to classify its training set (2401 mutagens and 1936 non-mutagens) with an accuracy of 82%. 
The Laboratory of Mathematical Chemistry (LMC, Bourgas, Bulgaria) has developed a list of 17 SAs. 
These are implemented in the OASIS TIMES software (see below).
More recently, Benigni and Bossa (2008) combined the above sources and some information from the 
OncoLogic software to generate a list of 33 SAs. Five of the Benigni-Bossa alerts refer to non-
genotoxic mechanisms of action and several of them have accompanying modulating factors. The 
reported accuracy of prediction is 78% for mutagenicity and 70% for carcinogenicity, based on an 
analysis of the ISSCAN database. The Benigni-Bossa SAs is implemented in the Toxtree software and 
in the OECD Toolbox (see below).
The relationships (overlaps) between the different lists of SAs are illustrated in Figure 2. For the 
purpose of this Venn diagram, comparison between alerts was based simply on the main functional 
group in the SA and not on exact matches between whole alerts. In the different lists, SAs are 
described with different levels of detail. At present, the most comprehensive list of SAs is the Benigni-
Bossa list (the number of the SAs containing in the Bailey list is the same but many of these alerts 
contain the same functional group and different substitutes). 
56. Types of expert systems 
An expert system has been defined as any formalised system that is often, but not necessarily, 
computer based, and that can be used to make predictions on the basis of prior information (Deaden et 
al., 1997). Expert systems (and their implementation in software tools) are based on three main 
modelling approaches referred to rule-based, statistically-based, or hybrid methods.
Rule-based systems contain “if-then-else” rules that combine toxicological knowledge, expert 
judgment and fuzzy logic. Commonly used software tools based on this approach include OncoLogic
(Woo et al. 1995), Derek (Sanderson & Earnshaw 1991; Ridings et al., 1996) and HazardExpert
(Smithing & Darvas 1992). Derek and HazardExpert can be used in conjunction with their sister 
programs Meteor and Metabolexpert to predict the genotoxicity and carcinogenicity potential of 
metabolites as well as parent compounds. In addition to these commercial tools, models included in the 
freely available Toxtree software and the OECD Toolbox are rule-based.
Statistically-based systems use a variety of statistical, rule-induction, artificial intelligence, and pattern 
recognition techniques to build models from non-congeneric databases. Statistically based systems are 
included in the commercial tools MultiCASE and TOPKAT, and the publicly available Lazar and 
CAESAR models. In addition, many models published in the literature and not implemented in 
software are statistically based.
Hybrid models are based on a combination of knowledge-based rules and statistically-derived models. 
These are based on the general idea that, within the structural space of a single SA (considered to 
represent a single interaction mechanism), statistically derived models can quantitatively predict the 
variation in the reactivity of the alert conditioned by the rest of the molecular structure. Examples of 
the hydrid approach include models implemented in the OASIS TIMES (Mekenyan et al,. 2004; 
Mekenyan et al., 2007; Serafimova et al., 2007) as well as some literature-based models not 
implemented in software. 
A good example of hydrid model in the literature is the Purdy model for carcinogenic potential (1996). 
Purdy’s model is a decision tree with 11 individual rules or QSARs for different chemical classes. The 
QSARs are relatively simple in form, ranging from an allowed range or cut-off of a computed property 
value (for example, logP, molecular volume, E(LUMO), partial atomic charges and 
superdelocalisibilities), to a three dimensional constraint specifying a fixed distance between lone pairs 
of electrons. The author reported a high accuracy of classification (92% and 88% for the training and 
test sets, respectively) The main advantages of the Purdy model is that is based on simple rules, and 
the reasoning underlying the prediction can be seen. The main disadvantages are that the rules is 
restricted to a few chemical classes and do not have clear mechanistically interpretations. In addition, 
the model is not yet automated so is not practically available for routine use. However, this limitation 
could easily be addressed by a software programmer.
The advantages and disadvantages of the three main approaches are summarised in Table 4.
7. Software tools
Genotoxicity and carcinogenicity prediction is featured in a wide range of commercial and freely 
available software tools, the most commonly used of which are described below. A summary is given 
in Table 5.
CAESAR: A statistical model for mutagenicity was developed and released as an open source 
software tool in the frame of the EU CAESAR project (http://www.caesar-project.eu/). Gini and 
colleagues (Ferrari et al., 2009) used the Support Vector Machine (SVM) classification method to 
develop a model based on the 4225 compounds from the Kazius-Bursi mutagenicity database. The 
authors reported correct classification rates of 92.3% and 83.2% for the training and test sets, 
respectively. The results were considered to be in the same order of magnitude as experimental error. 
No information was provided about the applicability domain. In order to minimise the number of false 
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Bossa rulebase (using Toxtree). As expected, the results showed that the number of false negatives 
could be reduced but this was at the expense of increasing the number of the false positives. This 
resulted in a slight change in accuracy of 1.1% less. The authors concluded that by using the so-called 
“cascade model”, a classification accuracy close to the reliability of the Ames test data could be 
achieved. In fact, they achieved this accuracy by using just the SVM classification algorithm.
In the CAESAR project, two complementary approaches (regression and classification) were applied 
to develop models for carcinogenicity. The original dataset, extracted from the CPDB, consisted of
805 chemicals with rat TD50 values. This dataset was spit into training (n=644) and test (n=161) sets. 
The regression model was developed by applying a Monte Carlo method to TD50 data. The 
classification model was developed by applying the Counter-Propagation Artificial Neural Network
(CP-ANN) method and a set of MDL descriptors. The authors reported an accuracy of classification of 
91-96% for the training set and 68-74% for the test set. 
Derek: This is a commercial system developed and marketed by Lhasa Ltd. The development of 
knowledge-based rules in Derek is overseen by collaborative group which consists of representatives 
from commercial, educational and non-profit organisations. The current version of Derek (v. 12; 
released in December 2009) contains 89 alerts for mutagenicity, 77 for chromosome damage, and 61
for carcinogenicity. The chromosome damage alerts are based primarily on data from the in vitro 
chromosome aberration test, however additional assays (in vivo chromosome aberration test, in vitro 
and in vivo micronucleus test and L5178Y TK+/- assay) have been considered when writing alerts, and 
some alerts are entirely based on alternative assays. The chromosome damage alerts cover both direct 
DNA damage and other genotoxic mechanisms.
The hazard assessment in Derek is usually justified with relevant literature references, which give the 
user more confidence in the predictions. The main advantages of the system are the transparency in the 
predictions, the fact that the rule development is peer-reviewed by a user group, and new rules can be 
added easily. It should be noted that DfW does not provide negative predictions (the absence of a 
predicted hazard simply means that no relevant alerts were identified; it does not necessarily mean the 
absence of hazard). A QMRF for the DfW mutagenicity model is available in the JRC QSAR Model 
Database.
In a recent study, Crettaz and Benigni (2005) assessed the ability of DfW to qualitatively predict the 
rodent carcinogenicity and the genotoxic potential of 60 pesticides registered in Switzerland. The 
percentage of false negatives was 31% for carcinogenicity. The associated sensitivity of 69% indicates 
that most of the pesticides with positive rodent bioassay results were detected by DfW. On the other 
hand, the low specificity of 47% is equivalent to a false positive rate of 53%. Such chemicals would be 
predicted as carcinogenic while rodent bioassays would not confirm this potential. 
In a recent EFSA-sponsored study on the applicability of TTC concept to pesticides and their 
metabolites carried out by the Chemicals Regulation Directorate (UK), DfW was used to predict the 
genotoxicity and carcinogenicity of 100 randomly selected pesticide active substances (CRD, 2009). It 
was concluded that DfW is not reliable predictor for these two endpoints. However, authors note that 
the dataset of 100 compounds is inevitably biased by excluding compounds with high genotoxic 
potential. When the analysis focused on compounds of greatest potential concern, those with positive 
study results for both tumours and genotoxicity, the predictivity based on an alert for either 
genotoxicity or carcinogenicity was good (10/12 correct), although the ratioanle for the prediction was 
often incorrect. It was concluded that additional work should be performed on the reliability of 
genotoxicity predictions from DfW and other (Q)SAR programs.
HazardExpert:  The HazardExpert models (Smithing and Darvas, 1992) are proprietary, the software 
now being marketed by CompuDrug Ltd. The program works by searching the query structure for 
known toxicophores that are derived from the literature in the field of QSAR or from the US EPA and 
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taking into account the effects of bioavailability and bioaccumulation. 
As an evaluation of its ability to predict human and animal carcinogenicity, 192 agents evaluated in the 
IARC Monographs (volumes 1-42) were processed through Hazardexpert (Dearden et al., 1997). The 
difference between the classification in the IARC list and that assessed by Hazardexpert was used for 
the analysis. As a result, some important fragments were found to be missing from the toxic fragments 
database, including vinyl chlorides, organophosphates, organometallic compounds, and isocyanates. 
In a separate evaluation study based on 80 NTP chemicals (56 rodent carcinogens; 24 non-
carcinogens), HazardExpert was found to have an overall concordance of 51%, and to be good at 
identifying non-carcinogens (specificity of 81%), but poor at identifying carcinogens (sensitivity of 
36%). 
Lazar: The predictive performance of Lazar was assessed by Helma (2006), who used a training set of 
1447 chemicals from the CPDB and 4337 chemicals from the Kazius/Bursi database for external 
validation. Leave-one-out and external validation experiments indicated that Salmonella mutagenicity 
can be predicted with 85% accuracy for compounds within the applicability domain of the CPDB. The 
LOO accuracy of Lazar predictions for rodent carcinogenicity was reported as 86%, and the accuracies 
for other carcinogenicity endpoints varied between 78 and 95% for structures within the applicability 
domain. A QMRF for Lazar mutagenicity is under preparation.
MDL QSAR: This is a commercial software tool originally developed by MDL and now marketed by 
Symyx Ltd (see above). The software has been used by Contrera et al. (2005a) to develop discriminant 
models for bacterial mutagenicity using a dataset of over 3000 chemicals and with sensitivity, 
specificity and concordance of 81%, 76% and 81%, respectively. These models are not readily 
transferable and thus of limited practical used. 
Valerio et al. (2007) evaluated the utility of a discriminant analysis modelling approach (MDL-QSAR) 
to estimate the carcinogenic potential of small, organic, naturally occurring chemicals found in the 
human diet. They used as a training set of over 1200 chemicals, comprised primarily of 
pharmaceuticals, industrial chemicals and some natural products. A sample set of 123 naturally 
occurring chemicals found in the human diet with known low and high risk potential as rodent 
carcinogens, and a control group of 19 synthetic dietary chemicals with known high carcinogenic 
potential were use as a test set. The predictive performance based on this test set was an overall 
concordance of 80%, a sensitivity of 97%, and a marginal specificity of 53%. These results support the 
usefulness of the MDL-QSAR software in identifying the rodent carcinogenic potential of naturally 
occurring organic chemicals. As also noted by the authors, further assessment of the software will be 
needed for a wider range of dietary chemicals.
MultiCASE: The MultiCASE models are proprietary. The software has been widely used by the 
Danish EPA to build models for a range of genotoxicity and carcinogenicity endpoints. Genotoxicity 
models include Ames mutagenicity (two models), direct mutagenicity, base-pair mutagenicity, frame-
shift mutagenicity, chromosomal aberrations (two models), mouse micronucleus assay, mouse sister 
chromosomal exchange. Carcinogenicity models include rat, mouse, female, male carcinogenicity, 
TD50 rat, mouse carcinogenicity. The Danish EPA reported concordances between 56-100% for the 
different models (http://www.mst.dk/English/Chemicals/Substances_and_materials/QSAR/). More 
information on these models, and pre-generated predictions for over 166,000 chemicals and can be 
found at the EPA website (http://www.mst.dk/English/Chemicals/) as well the as JRC website 
(http://ecbqsar.jrc.it/). The JRC version of the Danish database includes a flexible system for chemical 
structure and property searching.
In a study by Matthews and Contrera (1998), MCASE was used with numerous in-house modifications 
of the system, including: a) enhancement of the size of the control database modules; b) optimization 
of MCASE SAR assay evaluation criteria; c) incorporation of a carcinogenic potency scale for control 
compound activity and MCASE biophores; d) construction of individual rodent gender and species-
8specific modules; and e) use of assay acceptance criteria for query and control database compounds. 
The optimised system was reported to demonstrate excellent sensitivity for carcinogens (97%), and 
specificity for non-carcinogens (98%), in a test set of 126 chemicals. While these seem like very 
promising results, they are not verifiable: the MCASE model is not readily transferable, and the data 
used are confidential and therefore are not available for use in the development other modelling 
methodologies or to assist in the assessment of the improved MCASE system. Similar studies have 
been carried out more recently by Matthews and co-workers, with more extensive datasets (Matthews 
et al., 2006a, 2006b).
OASIS/TIMES: The hybrid approach has been used by Mekenyan and colleagues to develop models 
for Ames mutagenicity and chromosomal aberration. These models are implemented in the OASIS 
TIMES software. Each SA is accompanied by modulating factors, to account for the influence of the 
rest of the molecule, as well as with defined and documented mechanism of interaction with DNA (for 
the mutagenicity model) and/or nuclear proteins and enzymes (for the chromosomal aberration model). 
Expert knowledge was used to define the SAs and the mechanistic basis for prediction (interaction 
with biological macromolecules) is well documented. A pattern recognition approach (COREPA) was 
used to derive modulating factors for each SA. 
In contrast to other models for genotoxicity, the OASIS models include a liver metabolic simulator 
based on documented metabolic pathways. The training sets used for the models were split into 
chemicals that are mutagenic without metabolic activation, mutagenic after metabolic activation, and 
non mutagenic with and without metabolic activation. This is an important advantage of the 
OASIS/TIMES software, because the role of metabolism is rarely accounted for. To demonstrate the 
importance of metabolism, the authors showed that when predictions are obtained without using the 
metabolic simulator for chemicals known to be active after metabolic activation, the sensitivity was 
dramatically decreased to 22%. The main disadvantage of the OASIS/TIMES software is that it is a 
little bit slower than other software. 
OECD Toolbox: The current version of this software (http://toolbox.oasis-lmc.org) implements two 
so-called “profilers” connected with genotoxicity and carcinogenicity. The first one is the Benigni-
Bossa rulebase (Benigni et al., 2008b) and the second is the OASIS DNA binding profiler developed 
by LMC Bourgas (Serafimova et al., 2007). The OECD Toolbox also includes a few databases with 
experimental data that can be used to support grouping and read-across: a) the ISSCAN database –
1149 chemicals containing data for carcinogenicity and Ames mutagenicity; b) the EXCHEM database 
– 256 chemicals containing data for Ames mutagenicity, chromosomal aberrations and mouse 
micronucleus assay; c) the OASIS Genotox database – 2684 chemicals with data for Ames 
mutagenicity and chromosomal aberrations as well as data for metabolism. The Toolbox also includes 
the Danish EPA database containing predicted data of different genotoxicity and carcinogenicity 
endpoints for more than 166,000 chemicals.  
Oncologic: Oncologic is a knowledge-based system developed by LogicChem Inc (Woo & Lai, 2005). 
It can be freely download from the US EPA website 
(http://www.epa.gov/oppt/newchems/tools/oncologic.htm). It uses a series of hierarchically ordered 
rules to describe and predict the carcinogenic potential of chemicals. These rules have been developed 
in collaboration with the structure-activity team at the US EPA’s Office of Pollutions Prevention and 
Toxics. The current version (December 2009) includes over 40,000 rules based on knowledge and 
generalisations derived from the examination of more than 10,000 chemicals belonging to 
approximately 50 chemical classes. The main advantages of the system are that it includes a large 
amount of human knowledge, the predictions are restricted to those classes for which adequate 
knowledge is available, and reports usually include supporting information to justify the prediction. 
The main disadvantages are that there is no possibility for batch calculations, and the system requires 
some chemistry expertise, with the user needed to take decisions step-by-step during the prediction.
TOPKAT: The TOPKAT models are proprietary. According to Enslein (1994), the accuracy of 
mutagenicity and carcinogenicity predictions are extremely high: 98% (against a mutagenicity dataset 
9of 1083 chemicals) and 99.6% (against a carcinogenicity dataset of 705 chemicals), respectively. 
However, some subsequent evaluation studies (Prival 2001) indicate that for external sets of 
chemicals, the accuracy of TOPKAT prediction is considerably lower (40-75% against datasets of 30-
40 chemicals) and these results were not significantly better when the analyses were restricted to 
predictions made inside the OPS.
Toxtree: Toxtree currently includes two modules for mutagenicity and carcinogenicity prediction –
the Benigni-Bossa rulebase (which expands on the Ashby supermutagen model; see above) and the 
ToxMic rulebase for the in vivo micronucleus assay (Benigni et al., 2010). The developers have 
reported an accuracy of prediction around 70% for carcinogenicity, 78% for mutagenicity and 59% for 
the in vivo micronucleus assay (Benigni et al., 2009).
MolCode Toolbox: This commercial tool developed and marketed by Molcode Ltd includes modules 
for Ames mutagenicity and female rat carcinogenicity.
8.  Literature reviews and comparative evaluation studies
The literature relating to the in silico prediction of genotoxicity and carcinogenicity is huge, with more 
than 100 papers dedicated to (Q)SARs. A list of reviews, expert opinions and evaluation studies is 
given in Table 6, whereas details of primary research studies published in the past 10 years for 
genotoxicity and carcinogenicity models are given in Tables 7 and 8, respectively. Given the extent of 
the literature in this field, this section focuses on key findings from evaluation studies that have 
compared the performances of different models, including software models. A number of such “multi-
model evaluation studies” have been published (Table 6), which have been well summarised by 
Benigni et al. (2007). A representative selection of evaluation studies is described below.
Zeiger et al. (1996) used 100 NTP chemicals to compare ability of two computer systems (TOPKAT 
and CASE), one physicochemical screening test and one human expert system to predict Salmonella 
whereas the physicochemical system produced a lower (61%) concordance. Similar results for DfW 
and TOPKAT were reported by Cariello et al. (2002) - the accuracy of prediction of Ames 
mutagenicity by DfW was 65% (against a dataset of 400 GlaxoSmithKline chemicals). The overall 
concordance for TOPKAT was 73% but it should also be noted that TOPKAT was capable to predict 
300 out of the 400 chemicals.
Two other evaluation exercises were devised by the NTP. In the first exercise (Benigni 1997),
regarding the prediction of rodent carcinogenicity for 44 chemicals, different approaches were 
compared: computer-based systems (CASE, TOPKAT, DfW, COMPACT), human experts (Benigni, 
Tennant and Ashby, Weisburger and Lijinsky) and experimental data. For the structure-based 
approaches the overall accuracy was in the range 50-65%, whereas the Tennant and Ashby approach 
attained an accuracy of 75%. In the second exercise, based on 30 chemicals, the list of methods was 
extended. In this second exercise, the highest overall accuracy achieved was 60-65% (Benigni and 
Zito, 2004).
An informative survey was performed by Benigni and Bossa (2008). They summarised the outcomes 
of a series of external prediction exercises performed by various investigators with three non-local 
models in the commercial domain: MultiCase, TOPKAT, and DfW. The results included those 
obtained in the prospective prediction exercises by the NTP as well as several studies performed by 
companies using in-house datasets. The common characteristic of these studies is that the chemicals to 
be predicted were different from those used in the training sets by the model developers, and were 
performed independently. It was found that the predictions for external chemicals vary considerably 
both in terms of overall accuracy and in terms of relative proportions of true and false positives. As an 
example, Figure 3. shows a Receiver Operating Curve (ROC) graph which summarises the predictive 
performance of the DfW software system in a series of external prediction exercises for 
carcinogenicity (a) and mutagenicity (b). In the ROC Curve, a perfect performance would be in the 
top-left corner (100% true positives, 0% false positives). The line represents performances that could 
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be obtained by chance, so for a model to be better than chance, it needs to be in the top-left quadrant of 
the figure. The observations for TOPKAT and MultiCase were similar to those for DfW. These 
findings contrast with the usually good performances reported by the model developers, as assessed on 
large non-congeneric databases.
Mayer et.al. (2008) compared the abilities of several computer-based models (OncoLogic, 
MultiCASE, Ashby-Tennant structural alerts) to predict carcinogenicity with several genotoxic tests 
(Ames, mouse lymphoma assay and chromosomal aberration). Using data for 650 chemicals from the 
CPDB database, the authors found that the (Q)SAR methods produced a higher concordance frequency 
(71% to 88% versus 62% to 75% for genetic tests) and lower percentage of false negatives (8.6% to 
27% versus 20% to 39% for genetic tests). 
Similar findings were reported by Snyder (2009) who compared the carcinogenicity test results of 545 
marketed drugs with genotoxicity assay results. The data were taken primarily from the Physicians 
Desk Reference (PDR; 1999-2008). The analysis included an evaluation of the predictivity of Derek
and MCASE/MC4PC. The authors reported a low predictability of carcinogenicity based on the 
genotoxic assays. The two software programs performed reasonably well, and better than the in vitro 
genotoxic assays, in terms of high specificity (low percentage of false positives) and overall 
concordance. The weakness of the software was the low sensitivity of both programs, but it was still 
higher than that performed from in vitro assays.
Building on the study using MDL QSAR study by Valerio and colleagues (2007), Mazzatorta et al.
(2009) examined the performance of a wider series of in silico tools for predicting the carcinogenicity 
of natural chemicals. They extracted 50 chemicals from the Valerio data set, the majority of which 
were pyrrolidine alkaloids and phenolic-type compounds (20 high-risk and 30 low-risk chemicals in 
terms of carcinogenicity) and they applied two statistical models (MC4C and Lazar) and three 
knowledge-based expert systems (Toxtree, Derek and OncoLogic). Based on the results, the authors 
categorised the models into three performance groups. The first group - high sensitivity (>90%) and 
low to medium specificity (<68%) - includes OncoLogic. The second group - medium sensitivity and 
specificity (between 58 and 80%) - includes MC4PC and Lazar. The third group - low sensitivity 
(<41%) and high specificity (>74%) includes Derek and Toxtree. These results indicate that the 
carcinogenicity potential of naturally occurring chemicals can be reliably predicted by using a battery 
of software tools that combine high sensitivity (thereby minimising false negatives) and high 
specificity (thereby minimising false positives).
The battery approach was also investigated by Matthews et al. (2008), who explored the combined use 
of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM and Derek in predicting carcinogenic 
potential. They found that the use positive predictions from any two programs showed better overall 
performance than use of the single programs alone, with a sensitivity of about 85% and specificity of 
58%. When focussing on defined modes of action, the authors reported that consensus positive 
predictions of carcinogenicity by two QSAR programs could detect 99% of the carcinogens (including 
both genotoxic and nongenotoxic carcinogens) in the study.
The results of (Q)SAR evaluation studies such as those described here can also be placed into context 
by considering the results of a study by Kirkland et al. (2005) who evaluated the abilities of some of 
the most commonly used in vitro genotoxicity tests (Ames, mouse lymphoma assay [MLA], in vitro 
micronucleus [MN] and chromosomal aberrations [CA] as well as battery of three of these tests) to 
discriminate rodent carcinogens from non-carcinogens. The authors based their comparison on a large 
dataset of over 700 chemicals compiled from the CPDB, NTP and IARC databases as well as other 
publications. It was found that combinations of two and three test systems had greater sensitivity than 
individual tests resulting in sensitivities of around 90% or more, depending on the test combination 
The sensitivity of individual methods was between 59% (for Ames for over 500 chemicals) and 79% 
(for MN for over 80 chemicals). The specificity of the Ames test was reasonable (73.9%), but all 
mammalian cell tests had a low specificity (below 45%), and this was reduced in combinations of two 
and three test systems. When a battery of three tests was investigated, 75–95% of the non-carcinogens 
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were incorrectly predicted (i.e. were false positives) results in at least one test in the battery. This 
highlights deficiencies in the current ability to extrapolate from in vitro mutagenicity results to in vivo 
carcinogenicity.
In a recent study by Hansen et. al. (2009), and a large Ames mutagenicity data set comprising about 
6500 non-confidential compounds was compiled and made publicly available (http://ml.cs.tu-
berlin.de/toxbenchmark/). They used the dataset to compare the predictive performances of three 
commercial tools  (Derek, MultiCASE, and an off-the-shelf Bayesian machine learner in Pipeline 
Pilot) with four non-commercial machine learning implementations (Support Vector Machines, 
Random Forests, k-Nearest Neighbours, and Gaussian Processes). PipelinePilot, trained with the 
developed data set, showed the best predictive perfromance of the three commercial tools followed by 
MultiCASE. The expert system Derek gave the lowest sensitivity and specificity of all considered 
models. However, closer examination of the results reveals that the difference between the best 
commercial model (Pipeline Pilot) and the best machine learning approach (SVM) is a sensitivity of 
just a few percent, so it is difficult to draw firm conclusions. In general, machine learning algorithms 
are expected to perform better in cases such as this where they derive their knowledge exclusively 
from the training data, as opposed to models such as MultiCASE and Derek, which have rules derived 
from other datasets ot based on expert knowledge. This study is useful not only in terms of the dataset 
which is made publicly available, but also because it demonstrates the power of machine learning 
approaches. Such approaches are particularly useful in model discovery, after which optimal models 
could be used as the basis for developing models with a mechanistic basis.
9. Conclusions
When considering computational models for genotoxicity and carcinogenicity prediction, it should be 
remembered that these endpoints are based on multiple mechanisms of action, and are experimentally 
assessed by multiple tests, the results of which require expert interpretation. Thus, the in silico models 
are often modelling the “higher-level” interpretation of one or more experimental results rather than 
the “lower-level” experimental data themselves. This is different to models for some other endpoints 
(e.g. acute toxicity) where the models can be based directly on experimental data (e.g. LD50 values).    
At present, (Q)SAR methods are more reliable for predicting genotoxic potential than carcinogenic 
potential. Carcinogenicity prediction represents a considerable challenge due to the multitude of 
possible mechanisms of toxic action. The prediction of non-genotoxic carcinogenicity and 
carcinogenicity in humans is especially problematic. Models for predicting carcinogenic potency are 
lacking.
The accuracy of Ames mutagenicity prediction is typically 70-75%, whereas for carcinogenicity it is 
generally between 50-75%, depending on the (Q)SAR and dataset used. This is reasonable taking into 
account the complexity of the carcinogenicity endpoint, and the fact that models do not explicitly 
include ADME properties, which could be critical steps in the carcinogenic process. An important 
direction for future research would be to incorporate ADME considerations in the overall prediction. It 
will also be important to build more models for non-genotoxic mechanisms of action.
When evaluating (Q)SARs and software models on the basis of published papers, it is easy to obtain 
mixed messages. Thus, it is important to critically evaluate the design of the study. The accuracy of 
model prediction reported by the model developers is usually quite high for both training and test sets. 
However, this can be deceiving and is generally a consequence of the way in which the training and 
test sets were formed by splitting available datasets. In contrast, the accuracy of the prediction for 
external and independently chosen test sets is not so high. 
When using computational models for regulatory purposes, it is concluded that predictions of 
genotoxicity and carcinogenicity should not be based on the use of any single model alone, but on a 
Weight of Evidence approach including information is possible from all available sources (QSARs, 
read across, in vitro test methods). Studies such as those performed by Valerio et al. (2007), Coterrill 
12
et al. (2008) and Mazzatorta et al. (2009) support the usefulness of computational tools, especially 
when used in batteries that combine high sensitivity models (to minimise false negatives) with high 
specificity models (thereby minimising false positives). Building on such studies, there is a need for 
further research aimed at developing and assessing model batteries and integrated testing strategies for 
genotoxicity and carcinogenicity. 
As with all endpoints, predictions should always be interpreted by an expert with knowledge of the 
endpoint and an appreciation of the strengths and limitations of the specific model applied. An 
essential piece of information is the applicability domain of the model, and the reliability of prediction 
for the chemical of interest. Unfortunately, this information is often not available or easily obtained. 
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Figure 1. Ashby’s poly-carcinogen model, modified after Ashby and Tennant (1988) and Tenant and 
Ashby (1991)
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Figure 2. Comparison between the Ashby, Benigni-Bossa, LMC, Bailey and Kazius lists of SAs 
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Figure 3. Receiver Operating Curve (ROC) graph for the performance of the Derek software system in a 
series of external prediction exercises for carcinogenicity (a) and mutagenicity (b). The codes make 
reference to the following datasets or original studies: (a): Hulzebos 2003, Bayer 2003, IUCLID 2003, 
Pearl 2001, NTP1, NTP2, and Crettaz 2005. (b) Hulzebos 2003, Bayer 2003, Amines, IUCLID 2003, 
Cariello 2002, Greene 2002, Snyder 2004, Pearl-a 2001 and Pearl-b 2001, and Crettaz 2005 (sfter Benigni 
and Bossa 2008)
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12. Tables
Table 1. Genotoxicity test methods and endpoints
Test  method Genotoxic endpoints EU method / 
OECD guideline
In vitro test methods
Bacterial reverse mutation test - Ames Mutagenicity: gene mutations EU B.12/13
OECD 471
In vitro mammalian cell gene mutation test –
hprt test
Mutagenicity: gene mutations EU B.17
OECD 476
In vitro mammalian cell gene mutation test –
Mouse lymphoma assay
Mutagenicity: gene mutations and 
structural chromosome aberrations
EU B.17
OECD 476
In vitro mammalian chromosome aberration 
test
Mutagenicity: structural and numerical 
chromosome aberrations
EU B.10
OECD 473
In vitro micronucleus test Mutagenicity: structural and numerical 
chromosome aberrations
EU (none)
OECD 487 (draft)
In vivo test methods, somatic cells
In vivo mammalian bone marrow 
chromosome aberration test
Mutagenicity: structural and numerical 
chromosome aberrations
EU B.11
OECD 475
In vivo mammalian erythrocyte micronucleus 
test
Mutagenicity: structural and numerical 
chromosome aberrations
EU B.12
OECD 474
Unscheduled DNA synthesis (UDS) test in 
mammalian liver cells in vivo
Genotoxicity: DNA repair EU B.39
OECD 486
Transgenic animal models Mutagenicity: gene mutations EU (none)
OECD (none)
In vivo alkaline single-cell gel electrophoresis 
assay for DNA strand breaks (Comet assay)
Genotoxicity: DNA strand breaks EU (none)
OECD (none
Mammalian bone marrow Sister Chromatid 
Exchanges (SCE)
Genotoxicity: DNA strand breaks and 
DNA adduct formation
In vivo test methods, germ cells
Mammalian spermatogonial chromosome 
aberration test
Mutagenicity: structural and numerical 
chromosome aberrations
EU B.23
OECD 483
Rodent dominant lethal test Mutagenicity: structural and numerical 
chromosome aberrations
EU B.22
OECD 478
Transgenic animal models Mutagenicity: gene mutations EU none
OECD none
In vivo alkaline single-cell gel electrophoresis 
assay for DNA strand breaks (Comet assay)
Genotoxicity: DNA strand breaks EU none
OECD none
Unscheduled DNA synthesis (UDS) test in 
testicular cells in vivo
Genotoxicity: DNA repair
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Table 2.  Regulatory classification criteria for mutagenicity and carcinogenicity
EU criteria UN GHS criteria
MUTAGENICITY
CATEGORY 1: substances known to be mutagenic 
to man. 
There is sufficient evidence from epidemiological 
studies to establish a causal association between 
human exposure to a substance and heritable genetic 
damage.
Risk phrase: R46 May cause heritable genetic 
damage.
CATEGORY 1: known to induce heritable mutations 
or regarded as if they induce heritable mutations in the 
germ cells of humans.
CATEGORY 1A: substances known to induce 
heritable mutations in the germ cells of humans.
The classification in Category 1A is based on positive 
evidence from human epidemiological studies.
Health hazard code:
H340 May cause genetic defects
CATEGORY 2: substances which should be 
regarded as if they are mutagenic to man. 
There is sufficient evidence to provide a strong 
presumption that human exposure to the substance 
may result in the development of heritable genetic 
damage.
Risk phrase: R46 May cause heritable genetic 
damage
CATEGORY 1B: substances regarded as if they 
induce heritable mutations in the germ cells of 
humans.
Health hazard code:
H340 May cause genetic defects
CATEGORY 3:  substances which cause concern 
for man owing to possible mutagenic effects. 
There is evidence from appropriate mutagenicity 
studies, but this is insufficient to place the substance 
in category 2.
Risk phrase: R68 Possible risk of irreversible 
effects.
CATEGORY 2: substances which cause concern for 
humans owing to the possibility that they may induce 
heritable mutations in the germ cells of humans. 
Health hazard code:
H341 Suspcected of causing genetic defects
CARCINOGENICITY
CATEGORY 1: substances known to be 
carcinogenic to man. 
There is sufficient evidence to establish a causal 
association between human exposure to a substance 
and the development of cancer.
Risk phrases:
R45 May cause cancer
R49 May cause cancer by inhalation
CATEGORY 1: known or presumed human 
carcinogens.
A substance is classified in Category 1 for 
carcinogenicity on the basis of epidemiological and/or 
animal data. 
CATEGORY 2: substances which should be 
regarded as if they are carcinogenic to man. 
There is sufficient evidence to provide a strong 
presumption that human exposure to a substance 
may result in the development of cancer.
CATEGORY 1A: known to have carcinogenic 
potential for humans, classification is largely based on 
human evidence.
Health hazard code:
H350 May cause cancer
CATEGORY 1B: presumed to have carcinogenic 
potential for humans, classification is largely based on 
animal evidence.
Health hazard code:
H350 May cause cancer
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EU criteria UN GHS criteria
CATEGORY 3:  substances which cause concern 
for man owing to possible carcinogenic effects but in 
respect of which the available information is not 
adequate for making a satisfactory assessment. 
There is some evidence from appropriate animal 
studies, but this is insufficient to place the substance 
in category 2.
Risk phrase:
R40 Limited evidence of a carcinogenic effect
CATEGORY 2: suspected human carcinogens
The placing of a substance in Category 2 is done on 
the basis of evidence obtained from human and/or 
animal studies, but which is not sufficiently 
convincing to place the substance in Category 1A or 
1B.
Health hazard code:
H351 Suspected of causing cancer
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Table 3.  Public databases for genotoxicity and carcinogenicity
Database (name and link) Information
Benchmark Data Set 
for In Silico Prediction of Ames Mutagenicity
http://ml.cs.tu-berlin.de/toxbenchmark/
Ames mutagenicity databaset for 6500 compounds, 
made freely available by Berlin University of 
Technology. Downloadable sdf files.
Carcinogenic Potency Database (CPDB)
http://potency.berkeley.edu/cpdb.html
Contains of the results of 6540 chronic, long-term animal cancer 
tests on 1547 chemicals
Danish QSAR database
EPA site: http://130.226.165.14/index.html
JRC site: http://ecbqsar.jrc.ec.europa.eu/
Searchable database of predictions for approx 
166,000 chemicals. The predictions are based on 
MulitCase models developed by the Danish EPA.
DSSTox (Distributed Structure-searchable 
Toxicity) database
www.epa.gov/ncct/dsstox
The DSSTox website provides a public forum for publishing 
downloadable, structure- searchable, standardized chemical 
structure files associated with toxicity data
GAP – Genetic Activity Profile Database 
initially developed by US EPA and IARC, 
and now by ILS (http://www.ils-inc.com). CD 
rom available on request
Data on approx 300 chemicals from volumes 1-50 of the IARC 
Monographs and on 115 compounds identified as Superfund 
Priority Substances. Latest update in 2000.
European Chemical Substances Information
System (ESIS). Freely accessible from the 
JRC ex-ECB website:
http://ecb.jrc.ec.europa.eu/esis/
Information on chemicals related to: EINECS, the European List 
of Notified Chemical Substances (ELINCS); No-Longer 
Polymers (NLP) list; High Production Volume Chemicals 
(HPVCs); Low Production Volume Chemicals (LPVCs); 
Classification and Labelling (C&L); IUCLID chemical data 
sheets; EU priority lists and risk assessments performed under 
the Existing Substances Regulation (ESR); active substances 
listed on Annex 1 or 1A of the Biocidal Products Directive as 
well as substances that are “non-inclusions”;  Existing 
Substance evaluated in relation to their PBT properties.
Existing Chemicals Examination (EXCHEM) 
database  (Japan)
http://dra4.nihs.go.jp/mhlw_data/jsp/SearchPa
geENG.jsp
Contains data for Ames mutagenicity, chromosomal 
aberrations and mouse micronucleus assays for more 
than 250 HPV chemicals
Istituto superiore di Sanità database 
(ISSCAN) 
http://www.iss.it/ampp/dati/cont.php?id=233
&lang=1&tipo=7
Contains information on more than 1150 chemical compounds 
tested with the long-term carcinogenicity bioassay on rodents as 
well as mutagenicity data for more of them.
Monographs on the Evaluation of 
Carcinogenic Risks to Humans 
http://monographs.iarc.fr/index.php
A series of scientific reviews that studied more than 900 agents 
and have identified more than 400 known, probable and possible 
carcinogens.
National Toxicology Program (NTP) 
database 
http://ntp.niehs.nih.gov
Contains data from more than 500 two-year, two species, 
toxicology and carcinogenesis also contains results collected on 
approximately 300 toxicity studies from shorter duration tests 
and from more than 2000 genetic toxicity studies, some of 
which include both in vitro and in vivo tests
Toxicity Reference Database (ToxRefDB)
http://www.epa.gov/ncct/toxrefdb/
Includes chronic, cancer, sub-chronic, developmental, and 
reproductive studies on 330 of chemicals, many of which are 
pesticide active ingredients
TOXNET database of the National Library of 
Medicine (NLM), including the 
Carcinogenesis Research Information System 
database (CCRIS) and the Genetic 
Toxicology Databank (GENE-TOX)
http://toxnet.nlm.nih.gov/
CCRIS contains over 9000 chemical records with animal 
carcinogenicity, mutagenicity, tumour promotion, and tumor 
inhibition test results. 
GENE-TOX contains genetic toxicology (mutagenicity) test 
data, resulting from expert peer review of the open scientific 
literature, on over 3000 chemicals
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Table 4. Comparison of three main approaches in expert systems 
Approach Advantages Disadvantages
Rule-based · mechanistically connected to the 
predicted endpoint
· provide reasoning for the 
predictions
· in many cases support the 
prediction with literature 
references or expert knowledge 
· often restricted and/or ill-defined 
applicability domain
· usually cannot explain differences of the 
activity within a chemical class
· usually have lower accuracy of the 
prediction than statistical models
Statistical · usually have high accuracy of the 
predictions
· can be use for preliminary research 
when mechanism of action is 
unknown 
· usually difficult to interpret the model 
predictions 
· often do not provide mechanistically 
reasoning of the predictions
· often non-transparent to the end-user 
Hybrid · combines advantages of rule-based 
and statistical approaches, 
including mechanistic 
interpretability (for SA part),  and 
overall accuracy
· likely to have restricted applicability 
domain
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Table 5. Software for genotoxicity and carcinogenicity
Software Availability Comments  (endpoints predicted, applicability and 
performance) 
CAESAR
http://www.caesar-project.eu/
Freely 
available
Mutagenicity, carcinogenicity
DfW (Lhasa Ltd.)
http://www.lhasalimited.org
Commercial Mutagenicity, chromosome damage, genotoxicity, 
carcinogenicity, peroxisome proliferation
GAP – Genetic Activity Profile 
Database developed by US EPA
Not readily 
available. 
Used in-house 
by US EPA
Data on 299 chemicals compiled by IARC and US EPA. 
Data are available on 299 compounds selected from 
volumes 1-50 of the IARC Monographs and on 115 
compounds identified as Superfund Priority Substances.
HazardExpert
http://www.compudrug.com
Commercial Mutagenicity, oncogenicity
Lazar 
http://lazar.in-silico.de
Freely 
available
Ames mutagenicity, carcinogenicity
MDL-QSAR
http://www.symyx.com/
Commercial Carcinogenicity
MolCode Toolbox
http://molcode.com/
Commercial Ames mutagenicity, carcinogenicity
Multicase (MCASE/MC4PC)
MultiCASE Inc
http://www.multicase.com
Commercial Research tool - applies a statistical approach that 
automatically identifies molecular substructures that have 
a high probability of being relevant to the observed 
biological activity. Requires a learning set comprised of a 
mix of active and inactive molecules of diverse 
composition. 
OASIS – TIMES
http://www.oasis-lmc.org
Commercial Ames mutagenicity, chromosomal aberrations
OECD Toolbox
http://toolbox.oasis-lmc.org
Freely 
available
Includes two so-called “profilers” associated with 
genotoxicity and carcinogenicity, as well as three 
databases with experimental data that can be used to 
support grouping and read-across
OncoLogic™
http://www.epa.gov/oppt/newchems
/tools/oncologic.htm
Freely 
available
Carcinogenicity 
PASS
Institute of Biomedical Chemistry of 
the Russian Academy of Medical 
Sciences, Moscow
http://ibmc.p450.ru/PASS//
Commercial Classification models giving probability of mutagenic 
effects. There are two models, one for Ames 
mutagenicity, and another covered multiplein vitro and in 
vivo mutagnicity endpoints in mammals.
TOPKAT (Accelrys)
http://www.accelrys.com
Commercial Ames mutagenicity, carcinogenicity
Toxtree
http://ecb.jrc.ec.europa.eu/qsar/
Freely 
available
Includes modules for mutagenicity, carcinogenicity, and 
the in vivo micronucleus assay
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Table 6. Reviews and single model evaluation studies on (Q)SARs for genotoxicity and 
carcinogenicity
Year Reference Comment
2010 Valerio Jr L, Arvidson K, Busta E, Minnier  B, Kruhlak N, Daniel Benz R (2010).
Testing computational toxicology models with phytochemicals. Molecular 
Nutrition and Food Research 54 (2), 186-194.
Comparative evaluation to 
screening phytochemicals
2010 Sushko I, Novotarskyi S, Körner R, Pandey A, Kovalishyn V, Prokopenko V, 
Tetko I (2010). Applicability domain for in silico models to achieve accuracy of 
experimental measurements. Journal of Chemometrics 24 (3-4), 202-208.
Applicability domain for 
AMES mutagenicity model
2010 Pérez-Garrido A, Helguera A, López G, Cordeiro M, Escudero A (2010). A 
topological substructural molecular design approach for predicting mutagenesis 
end-points of •, •-unsaturated carbonyl compounds. Toxicology 268 (1-2),  64-77.
Comparative evaluation of 
TOPS-MODE and Toxtree 
for •,•-unsaturated 
carbonyl compounds
2009 Snyder RD (2009). An update on the genotoxicity and carcinogenicity of 
marketed pharmaceuticals with reference to in silico predictivity. Environmental 
and Molecular Mutagenesis 50, 435-450.
Comparative evaluation of 
Derek, MC4PC, marketed 
pharmaceuticals
2009 Rothenbacher T & Schwack W (2009). Nontargeted multicomponent analytical 
screening of plastic food contact materials using fast interpretation of deliverables 
via expert structure-activity relationship software. Journal of AOAC International 
92(3), 941-950
Industry use of QSAR, 
Application of Derek to 
screening of plastic food 
contact materials
2009 Hansen K, Mika S, Schroeter T, Sutter A, ter Laak A, Steger-Hartmann T, 
Heinrich N & Mueller K-R (2009). Benchmark Data Set for in Silico Prediction of 
Ames Mutagenicity. Journal of Chemical Information and Modeling 49(9), 2077-
2081.
Comparative evaluation
2009 Mazzatorta P, Ringeissen S, Note R, Schilter B & Meunier JR (2009). In silico 
models to predict rodent carcinogenicity of naturally-occurring chemicals: 
comparative study and first insights into modes of action. Poster presentation at 
the Lhasa International Collaborative Group Meeting, November 2009
Comparative evaluation
2008 Kulkarni SA & Zhu J (2008). Integrated approach to assess the domain of 
applicability of some commercial (Q)SAR models. SAR and QSAR in 
Environmental Research 19(1-2), 39-54. 
Comparative evaluation
2008 Mayer JM et al. (2008). Structure–activity relationship analysis tools: Validation
and applicability in predicting carcinogens. Regulatory Toxicology and 
Pharmacology 50: 50-58.
Comparative evaluation
2008 Custer LL & Sweder KS (2008). The role of genetic toxicology in drug discovery 
and optimization. Current Drug Metabolism 9, 978-985.
Drug discovery and 
optimisation
2008 Benigni R & Bossa C (2008). Predictivity of QSAR. Journal of Chemical 
Information and Modeling 48, 971-980.
Comparative evaluation of 
different models 
2008 Benigni R & Bossa C (2008). Predictivity and reliability of QSAR models: The 
case of mutagens and carcinogens. Toxicology Mechanisms and Methods 18(2-3), 
137-147
Comparative evaluation of 
non-commercial QSARs
2008 Benigni R, Bossa C, Richard A & Yang C (2008). A novel approach: chemical
relational databases, and the role of the ISSCAN can database on assessing 
chemical carcinogenicity. Ann Ist Super Sanità 44(1): 48-56.
Databases  for genotoxicity 
and mutagenicity
2008 Saiakhov RD & Klopman G (2008). MultiCASE Expert Systems and the REACH 
Initiative. Toxicology Mechanisms and Methods 18(2-3), 159-175.  
2008 Contrera JF, Matthews EJ, Kruhlak NL & Benz RD (2008). In Silico Screening of 
Chemicals for Genetic Toxicity Using MDL-QSAR, Nonparametric Discriminant 
Analysis, E-State, Connectivity, and Molecular Property Descriptors. Toxicology 
Mechanisms and Methods 18(2-3), 207-216.
MDL-QSAR model for 
mutagenicity, 
clastogenicity and DNA 
damage
2008 Matthews EJ, Kruhlak NL, Benz RD, Contrera JF, Marchant CA & Yang C 
(2008). Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, 
and Derek for Windows Software to Achieve High-Performance, High-
Comparative evaluation
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Year Reference Comment
Confidence, Mode of Action-Based Predictions of Chemical Carcinogenesis in 
Rodents. Toxicology Mechanisms and Methods 18(2-3), 189-206.
2008 Yang C, Hasselgren CH, Boyer S, Arvidson K, Aveston S, Dierkes P, Benigni R, 
Benz RD, Contrera J & Kruhlak NL (2008). Understanding Genetic Toxicity 
Through Data Mining: The Process of Building Knowledge by Integrating 
Multiple Genetic Toxicity Databases. Toxicology Mechanisms and Methods 18(2-
3), 277-295.
2008 Cotterill JV, Chaudhry MQ, Matthews W & Watkins RW (2008). In silico 
assessment of toxicity of heat-generated food contaminants. Food and Chemical 
Toxicology 46, 1905–1918.
TOPKAT and Derek used 
for predicting 
carcinogenicity, 
mutagenicity and acute 
toxicity. 
2007 Benigni R., Netzeva T, Benfenati E, Bossa C, Franke R, Helma C, Hulzebos E, 
Marchant C, Richard A, Woo Y-T & Yang C (2007). The expanding role of 
predictive toxicology: An update on the (Q)SAR models for mutagens and 
carcinogens. Journal of Environmental Science and Health 25, 53–97.
Non-commercial QSARs 
2007 Kulkarni SA, Moir D & Zhu J (2007). Influence of structural and functional 
modifications of selected genotoxic carcinogens on metabolism and mutagenicity 
- a review. SAR and QSAR in Environmental Research 18(5-6), 459-514.
2007 Kruhlak N, Contrera J, Benz D & Matthews E (2007). Progress in QSAR toxicity 
screening of pharmaceutical impurities and other FDA regulated products.
Advanced Drug Delivery Reviews (2007), 59(1), 43-55.
FDA use of QSAR,
application to
pharmaceutical impurities
2007 Contrera JF, Kruhlak NL, Matthews EJ & Benz RD (2007). Comparison of 
MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement 
of predictive performance by combining QSAR models. Regulatory Toxicology 
and Pharmacology 49(3), 172-182.
Comparative evaluation
2007 Mazzatorta P, Tran L-A, Schilter B & Grigorov M (2007). Integration of 
Structure-Activity Relationship and Artificial Intelligence Systems To Improve in 
Silico Prediction of Ames Test Mutagenicity. Journal of Chemical Information 
and Modeling 47(1), 34-38.
Comparative evaluation
2006 Benigni R & Bossa C (2006). Structure-activity models of chemical carcinogens: 
state of the art, and new directions. Annali dell'Istituto Superiore di Sanita 42(2), 
118-126
2006 Greene N (2006). Computational models to predict toxicity. In Comprehensive 
Medicinal Chemistry II (Eds Taylor JB & Triggle DJ) 5, 909-932
2006 Dobo KL, Greene N, Cyr MO, Caron S & Ku WW (2006). The application of 
structure-based assessment to support safety and chemistry diligence to manage 
genotoxic impurities in active pharmaceutical ingredients during drug 
development. Regulatory Toxicology and Pharmacology 44(3), 282-293.
Industry use. Identification 
of impurities in active 
pharmaceutical ingredients 
during drug development
2006 Veith G (2006). Roles for QSAR in risk assessment. ALTEX Alternativen zu 
Tierexperimenten (2006), 23 Suppl, 369-72.
2006 Snyder RD, Ewing D & Hendry LB (2006). DNA intercalative potential of 
marketed drugs testing positive in in vitro cytogenetics assays. Mutation Research, 
Genetic Toxicology and Environmental Mutagenesis 609(1), 47-59.
2006 Cronin M (2006). The role of hydrophobicity in toxicity prediction. Current 
Computer-Aided Drug Design, 2(4), 405-413.
2005 Woo Y-T & Lai DY (2005). OncoLogic: A mechanism-based expert system for 
predicting the carcinogenic potential of chemicals. In Predictive Toxicology (C 
Helma, ed), 385-413.
2005 Parsons S & McBurney P (2005). The use of expert systems for toxicology risk 
prediction. In Predictive Toxicology (C Helma, ed), 135-175.
2005 Helguera A, Perez M, Combes R & Gonzalez M (2005). The prediction of 
carcinogenicity from molecular structure. Current Computer-Aided Drug Design, 
1(3), 237-255.
2005 Jacobs A (2005). Prediction of 2-Year Carcinogenicity Study Results for 
Pharmaceutical Products: How Are We Doing? Toxicological Sciences 88(1), 18-
Pharmaceutical products
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Year Reference Comment
23. 
2005 Benigni R (2005). Structure•activity relationship studies of chemical mutagens 
and carcinogens: Mechanistic investigations and prediction approaches. Chemical
Reviews 105 (5), 1767–1800.
2005 Snyder RD & Hendry LB (2005). Toward a greater appreciation of noncovalent 
chemical/DNA interactions: Application of biological and computational 
approaches. Environmental and Molecular Mutagenesis 45(2/3), 100-105.
Non-covalent binding of 
chemicals to DNA and 
genotoxicity
2005 Snyder RD & Smith MD (2005). Computational prediction of genotoxicity: room 
for improvement. Drug Discovery Today 10(16), 1119-1124.
2005 Hall LH & Hall LM (2005). QSAR Modeling Based on Structure-Information for 
Properties of Interest in Human Health. SAR and QSAR in Environmental 
Research 16(1-2), 13-41.
2963 compounds, 
including 290 therapeutic 
drugs, 400 in external 
validation
2005 Crettaz P & Benigni R (2005). Prediction of the Rodent Carcinogenicity of 60 
Pesticides by the DEREKfW Expert System. Journal of Chemical Information and 
Modeling 45: 1864-1873.
Evaluation of Derek
2005 Hulzebos E, Sijm D, Traas T, Posthumus R & Maslankiewicz L. (2005). Validity 
and validation of expert (Q)SAR systems. SAR and QSAR in Environmental 
Research 16(4), 385-401.
Comparative evaluation
2005 Hayashi M, Kamata E, Hirose A, Takahashi M, Morita T & Ema M (2005). In 
silico assessment of chemical mutagenesis in comparison with results of 
Salmonella microsome assay on 909 chemicals. Mutation Research, Genetic 
Toxicology and Environmental Mutagenesis 588(2), 129-135.
Comparative evaluation
2004 Combes R & Rodford R (2004). The use of expert systems for toxicity prediction 
- illustrated with reference to the DEREK program. In Predicting Toxicity and 
Fate (MTD Cronin and DJ Livingstone, Eds), CRC Press, 193–204.
2004 Benigni R (2004). Prediction of human health endpoints: mutagenicity and 
carcinogenicity. In Predicting Toxicity and Fate (Cronin M & Livingstone D, ed.), 
CRC Press, 173-192.
2004 Snyder RD, Pearl GS, Mandakas G, Choy WN, Goodsaid F & Rosenblum IY 
(2004). Assessment of the sensitivity of the computational programs DEREK, 
TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical 
molecules. Environmental and Molecular Mutagenesis 43(3), 143-158.
Evaluation of Derek, 
TOPKAT, MCASE.
Genotoxicity of 394 
marketed pharmaceuticals.
2004 Benigni R & Zito R (2004). The second National Toxicology Program 
comparative exercise on the prediction of rodent carcinogenicity: definitive 
results. Mutation Research, Reviews in Mutation Research, 566(1), 49-63.
Comparative evaluation
2004 Benigni R (2004). Chemical structure of mutagens and carcinogens and the 
relationship with biological activity. Journal of Experimental & Clinical Cancer 
Research 23(1), 5-8. 
2004 Rosenkranz HS (2004). SAR modeling of genotoxic phenomena: the consequence 
on predictive performance of deviation from a unity ratio of genotoxicants/non-
genotoxicants. Mutation Research, Genetic Toxicology and Environmental 
Mutagenesis 559(1-2), 67-71.
2004 Helma C, Cramer T, Kramer S & De Raedt L (2004).  Data Mining and Machine 
Learning Techniques for the Identification of Mutagenicity Inducing 
Substructures and Structure Activity Relationships of Noncongeneric Compounds. 
Journal of Chemical Information and Computer Sciences 44(4), 1402-1411. 
Comparative evaluation
2004 Votano JR, Parham M, Hall LH, Kier LB, Oloff S, Tropsha A, Xie Q & Tong W 
(2004). Three new consensus QSAR models for the prediction of Ames 
genotoxicity. Mutagenesis 19(5), 365-77.
Comparative evaluation
2003 Patlewicz G, Rodford R & Walker JD (2003). Quantitative structure-activity 
relationships for predicting mutagenicity and carcinogenicity. Environmental 
Toxicology and Chemistry 22(8), 1885-1893.
Describes Derek, 
TOPKAT, MCASE, 
ADAPT, QSAR-ES, 
COMPACT, COREPA
2003 Dearden JC (2003). In silico prediction of drug toxicity. Journal of Computer- Describes TOPKAT, 
MCASE, Derek, 
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Year Reference Comment
Aided Molecular Design 17(2-4), 119-127. Oncologic, HazardExpert, 
COMPACT
2003 Richard A & Williams C (2003). Public sources of mutagenicity and 
carcinogenicity data. In Quantitative Structure-Activity Relationship (QSAR) 
Models of Mutagens and Carcinogens (R Benigni, ed), pp 151-177. CRC Press.
Public sources of 
mutagenicity and 
carcinogenicity data
2003 Passerini L (2003). QSARs for individual classes of chemical mutagens and 
carciongens. In Quantitative Structure-Activity Relationship (QSAR) Models of 
Mutagens and Carcinogens (R Benigni, ed), pp 81-123. CRC Press.
Literature models for 
congeneric classes
2003 Benigni R, Giuliani A, Gruska A & Franke R (2003). QSARs for the mutagenicity 
and carcinogenicity of the aromatic amines. In Quantitative Structure-Activity 
Relationship (QSAR) Models of Mutagens and Carcinogens (R Benigni, ed), pp 
125-144. CRC Press.
Literature models for 
aromatic amines
2003 Schultz T, Cronin M & Netzeva T (2003). The present status of QSAR in 
toxicology. Journal of Molecular Structure-THEOCHEM 622, 23-38.
2003 Schultz T, Cronin M, Walker J & Aptula A (2003). Quantitative structure-activity 
relationships in (QSARs) in toxicology: A historical perspective. Journal of 
Molecular Structure-THEOCHEM 622, 1-22.
2003 White AC, Mueller RA, Gallavan RH, Aaron S & Wilson AGE (2003). A 
multiple in silico program approach for the prediction of mutagenicity from 
chemical structure. Mutation Research, Genetic Toxicology and Environmental 
Mutagenesis 539(1-2), 77-89.
Comparative evaluation of
TOPKAT, Derek, 
CASETOX. Test set 1- 520 
proprietary drug 
candidates; test set 2 - 94 
commercial componds
2003 Klopman G, Chakravarti S, Harris N, Ivanov J & Saiakhov R (2003). In-silico 
screening of high production volume chemicals for mutagenicity using the 
MCASE QSAR expert system. SAR and QSAR in Environmental Research 14(2), 
165-180.
Evaluation of MCASE. 
Test set of 2484 HPV 
chemicals with and without 
metabolic activation
2003 Toivonen H, Srinivasan A, King RD, Kramer S & Helma C (2003). Statistical 
evaluation of the Predictive Toxicology Challenge 2000-2001. Bioinformatics 
19(10), 1183-1193.
Comparative evaluation
2003 Mekenyan O, Dimitrov S, Schmieder P & Veith G (2003). In silico modelling of 
hazard endpoints: current problems and perspectives. SAR and QSAR in 
Environmental Research 14(5-6), 361-371.
2003 Cronin MT, Dearden J, Walker J & Worth A (2003). Quantitative structure-
activity relationships for human health effects: Commonalities with other 
endpoints. Environmental Toxicology and Chemistry 22(8), 1829-1843.
2003 Cronin MT, Jaworska J, Walker J, Comber M, Watts C & Worth A (2003). Use of 
QSARs in international decision-making frameworks to predict health effects of 
chemical substances. Environmental Health Perspectives 111(10), 1391-1401.
2003 Benigni R & Zito R (2003). Designing safer drugs: (Q)SAR-based identification 
of mutagens and carcinogens. Current Topics in Medicinal Chemistry 3(11), 
1289-1300.
2002 Greene N (2002). Computer systems for the prediction of toxicity: an update, 
Advanced Drug Delivery Reviews 54, 417–431.
Describes Derek, MCASE, 
TOPKAT, HazardExpert, 
TOXSYS, COMPACT, 
Oncologic
2002 Cariello NF et al. (2002). Comparison of the computer programs DEREK and 
TOPKAT to predict bacterial mutagenicity. Mutagenesis 17(4): 321-329.
Comparative evaluation
2002 Young R (2002). Genetic toxicology: Web resources. Toxicology 173(1-2), 103-
121.
Review of databases
2001 Prival MJ (2001). Evaluation of the TOPKAT System for Predicting the 
Carcinogenicity of Chemicals." Environmental and Molecular Mutagenesis 37: 
55-69.
Evaluation of TOPKAT
2000 Combes R. (2000). The use of structure-activity relationships and markers of cell 
toxicity to detect non-genotoxic carcinogens. Toxicology in Vitro 14(4), 387-399.
Identification of non-
genotoxic carcinogens
42
Year Reference Comment
1999 Zhu X, Zhang Y, Klopman G & Rosenkranz H (1999). Thalidomide and 
metabolites: indications of the absence of 'genotoxic' carcinogenic potentials.
Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis
425(1), 153-167.
Evaluation of MCASE, 
META in assessment of
thalidomide and 
metabolites
1999 Tuppurainen K (1999). Frontier orbital energies, hydrophobicity and steric factors 
as physical QSAR descriptors of molecular mutagenicity. A review with a case 
study: MX compounds. Chemosphere 38(13), 3015-3030.
1999 Fu P, Von Tungeln L, Chiu L-H & Own Z (1999). Halogenated-polycyclic 
aromatic hydrocarbons: A class of genotoxic environmental pollutants. Journal of 
Environmental Science and Health, Part C: Environmental Carcinogenesis & 
Ecotoxicology Review, C17(2), 71-109.  
1998 Henry B, Grantv S, Klopman G & Rosenkranz H (1998). Induction of forward 
mutations at the thymidine kinase locus of mouse lymphoma cells: evidence for 
electrophilic and non-electrophilic mechanisms. Mutation Research, Fundamental 
and Molecular Mechanisms of Mutagenesis 397(2), 313-335.
Evaluation of MCASE, 209 
chemicals
1998 Richard A (1998). Structure-based methods for predicting mutagenicity and 
carcinogenicity: are we there yet? Mutation Research, Fundamental and Molecular 
Mechanisms of Mutagenesis 400(1,2), 493-507
Describes TOPKAT, 
CASE/MCASE, Derek, 
Oncologic
1997 Dearden J et al. (1997). The Development and Validation of Expert Systems for 
Predicting Toxicity. ATLA 25, 223-252.
Describes Derek, CASE, 
COMPACT, TOPKAT, 
HazardExpert, Oncologic, 
REX, DTOX, PROLOG
1997 Polloth C & Mangelsdorf I (1997). Commentary on the application of (Q)SAR to 
the toxicological evaluation of existing chemicals, Chemosphere 35(11), 2525-
2542.
Commentary, with 
emphasis on
industrial (HPV) chemicals
1996 Marchant & Collaborative (1996). Prediction of Rodent Carcinogenicity Using the 
DEREK System for 30 Chemicals Currently Being Tested by the National 
Toxicology Program. Environmental Health Perspectives 104(5): 1065-1073.
Comparative evaluation
1996 Rosenkranz HS, Zhang YP & Klopman G (1996). Studies on the potential for 
genotoxic carcinogenicity of fragrances and other chemicals. Food and Chemical 
Toxicology 36(8), 687-696.
Comparative evaluation
1996 Zeiger E et al. (1996). Prediction of Salmonella mutagenicity. Mutagenesis 11(5): 
471-484.
Comparative evaluation
1996 Woo Y-T, Lai D, Argus M & Arcos J (1996). Carcinogenicity of 
organophosphorus pesticides/compounds: An analysis of their structure-activity 
relationships, Environmental Carcinogenesis & Ecotoxicology Reviews, C14(1), 
1-42.
Carcinogenicity of 
organophosphorus 
pesticides/compounds
1996 Lai D, Woo Y-T, Argus M & Arcos J (1996). Carcinogenic potential of organic 
peroxides: Prediction based on structure-activity relationships (SAR) and 
mechanism-based short-term tests. Environmental Carcinogenesis & 
Ecotoxicology Reviews, C14(1), 63-80.
Organic peroxides
1995 Rosenkranz H & Klopman G (1995). Structure-activity relationships as 
alternatives in the study of carcinogenesis, Alternative Methods in .Toxicology 
and the Life Sciences, 11 (The World Congress on Alternatives and Animal Use 
in the Life Sciences: Education, Research, Testing, 1993), 379-390.
1994 Vogel E & Ashby J (1994). Structure-activity relationships: experimental 
approaches. SCOPE 52, 231-54.
1994 Waters M, Richard A, Rabinowitz J, Stack F, Garrett N, Lohman P & Rosenkranz 
H (1994). Structure-activity relationships: computerized systems. SCOPE 52, 201-
29.
1994 Benigni R & Giuliani A (1994). Quantitative structure-activity relationship 
(QSAR) studies in genetic toxicology: mathematical models and the "biological 
activity" term of the relationship, Mutation Research, Fundamental and Molecular 
Mechanisms of Mutagenesis 306(2), 181-6.
1994 Klopman G & Rosenkranz H (1994). Approaches to SAR in carcinogenesis and 
mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE, 
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Year Reference Comment
Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis 
305(1), 33-46.
1994 Mersch-Sundermann V, Rosenkranz H & Klopman G (1994). The structural basis 
of the genotoxicity of nitroarenofurans and related compounds. Mutation Research
304(2), 271-84.
Evaluation of CASE, 79 
nitroarenofurans
1994 Eder E, Hoffman C, Deininger C & Scheckenbach S (1994). Risk assessment for 
mutagenic and carcinogenic activities of •,•-unsaturated carbonyl compounds by 
a screening strategy based on structure-activity relationships. Toxicology in Vitro
8(4), 707-10.
•,•-unsaturated carbonyl 
compounds
1992 Benigni R & Giuliani A (1992). QSAR studies in genetic toxicology: congeneric 
and noncongeneric chemicals. Archives of Toxicology, Supplement 15 (Med. 
Toxicol.), 228-237.
1991 Tenant RW & Ashby J (1991). Classification according to chemical structure, 
mutagenicity to Salmonella and level of carcinogenicity of a further 39 chemicals 
tested for carcinogenicity by the U.S. National Toxicology program. Mutation 
Research 257: 209-227.
Comparative evaluation
1991 Hansch C (1991). Structure-activity relationships of chemical mutagens and 
carcinogens Science of the Total Environment 109-110, 17-29.
1990 Waters M, Richard A, Rabinowitz J, Stack H & Garrett N (1990). Structure-
activity relationships. Computerized systems. EPA Report EPA/600/D-90/125; 
Order No. PB90-263476, 75.
1990 Rosenkranz HS & Klopman G (1990). Structural alerts to genotoxicity: the 
interaction of human and artificial intelligence. Mutagenesis 5(4), 333-61.
1990 Rosenkranz H & Klopman G (1990). Evaluating the ability of CASE, an artificial 
intelligence structure-activity relational system, to predict structural alerts for 
genotoxicity. Mutagenesis 5(6), 525-527.
Evaluation of CASE, 39 
chemicals
1990 Rosenkranz HS & Klopman G (1990). Structural implications of the ICPEMC 
method for quantifying genotoxicity data. Mutation Research 305(1), 99-116.
1990 Blake BW, Enslein K, Gombar VK & Borgstedt HH (1990). Salmonella 
mutagenicity and rodent carcinogenicity: quantitative structure-activity 
relationships. Mutation research 241(3), 261-71.
1989 Richard A, Rabinowitz J & Waters M (1989). Strategies for the use of 
computational SAR methods in assessing genotoxicity. Mutation Research, 
Reviews in Genetic Toxicology 221(3), 181-96.
1989 Miertus S, Frecer V & Majekova M (1989). QSAR and mechanistic studies on the 
genotoxic compounds including environmental effects. International Journal of 
Quantum Chemistry 35(1), 153-165.
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Table 7. Primary (Q)SAR studies on genotoxicity published in the past 10 years
Reference Chemical classes Dataset size
Bentzien et al. (2010) Primary aromatic amines 257
Pérez-Garrido et al. (2010) Acrylates, methacrylates and •,•-unsaturated 
carbonyl compounds
220 (Ames data)
48 (mammalian cells 
mutagenesis data)
Carlsson et al. (2009) Diverse compounds from CCRIS database 4254 
Hansen et al. (2009) Drugs + diverse compounds from CCRIS, VITIC, 
Genetox and published papers
6512 
Holder et al. (2009) Oxiranes (epoxides), nitrogen-containing 
molecules, and halogenated compounds
44
Onchoke (2009) Triphenylene, 1-, and 2-nitrotriphenylene 3
Rothenbacher et al. (2009) Polyethylene, and other substances from food 
packing materials
46
Toropov et al. (2009) Heteroaromatic amines 95 
Toropov et al. (2009) Nitrated polycyclic hydro-carbons 48
Venkatapathy et al. (2009) Diverse compounds from CPDB 590
Wang et al. (2009) Diverse compounds from CPDB 693
Wang et al. (2009) Polycyclic aromatic hydrocarbons 26
Contrera et al. (2008) Pharmaceuticals, food constituents, and 
environmental and industrial chemicals
1254 
Cunningham et al. (2008) Industrial chemicals 104
Didziapetris et al. (2008) Diverse compounds from CCRIS database 8000
Dorn et al. (2008) Steroids and other compounds 26
Du et al. (2008) Thiophene derivatives 140
Koleva et al. (2008) •,•-unsaturated carbonyl compound (aldehydes and 
ketones)
77
Kulkarni et al. (2008) Organic chemicals 11 
Langham et al. (2008) Diverse organic compounds from the CCRIS, 
Toxnet, NTP, CPDB and GAP databases
4737 
Nair et al. (2008) Nitroarenes 197 
Papa et al. (2008) Polycyclic aromatic hydrocarbons, oxo- and nitro-
and unsubstituted PAHs
70 
Perez-Garrido et al. (2008) Haloacetic acids, nitrohaloalkanes, haloacids, 
haloalde- hides, halocetones, haloalcohols, 
haloepoxides, and haloalkanes
42
Ruiz et al. (2008) Polychlorinated biphenyls 209
Singh et al. (2008) Nitrated polycyclic aromatic hydrocarbons 48
Zhang et al. (2008) Nitronaphthalenes and methylnitronaphthalenes 16
Benigni et al. (2007) Homocyclic aromatic amines 229 
Boerth (2007) Pesticides and metabolites N/A
Borosky (2007) Aromatic and Heterocyclic Aromatic Amines 17
Castro et al. (2007) Dental monomers 16 
Chroust et al. (2007) Halogenated aliphatic compounds 116 
Dorn et al. (2007) Lipophilic chemicals such as aliphatic hydrocarbons 
and alcohols, colcemid, cytochalasin B, diamide, 
nitrobenzene and benzonitrile, phytoestrogens 
genistein and daidzein, other hormonal steroids
33
Fang et al. (2007) Aromatic and heteroaromatic amines 80
45
Reference Chemical classes Dataset size
Gramatica et al. (2007) Nitrated Polycyclic Arom. Hydrocarbons 48
Gramatica et al. (2007) Benzocyclopentaphenanthrenes/chrysenes 32
Hu et al. (2007) Quinolone antibacterials 20 
Mazzatorta et al. (2007) Diverse compounds from the CCRIS database 5090
Sangamwar et al. (2007) Antifungal compounds, mainly azoles 30
Serafimova et al. (2007) Diverse compounds from NTP database and 
proprietary chemicals provided by BASF AG
2844 
Tekiner-Gulbas et al. (2007) 2,5-disubstituted benzoxazole and benzimidazole 
derivatives
21
Toropov et al. (2007) 1) organic compounds
2) heteroaromatic amines
3) TIBO (tetrahydroimidazobenzodiazepinone) and 
HEPT (hydroxyethoxymethylphenylthiothymine) 
derivatives
1) 44
2) 94
3) 32 
Valerio et al. (2007) Small organic naturally accurring chemicals found 
in the human diet
120
Xiao et al. (2007) Substituted phenols 29
Zhang et al. (2007) Organic compounds from the CCRIS, Toxnet, NTP, 
CPDB and GAP databases
4555
Buttingsrud et al. (2006) Aromatic and heteroaromatic nitro compounds 335 
Casalegno et al. (2006) Aromatic amines 100
Dobo et al. (2006) Pharmaceutical actives, impurities and 
intermediates 
272
Estrada et al. (2006) Organic compounds, drugs, food additives, 
agrochemicals, cosmetic materials,medicinal 
products, and household materials
372 
Hayashi et al. (2006) Diverse compounds: 703 from CGX database 
(Kirkland et al., 2005) and 206 existing chemicals 
from Japanese ECJ database
909 (703+206)
Helma (2006) Diverse compounds from CPDB 3895
Joshi et al. (2006) Phenyltriazenes 17
Kim et al. (2006) Benz[a]anthracene (BA), metabolic products -
polycyclic  aromatic  compounds  (PAH)  include  
BA-oxides,  -phenols,  - quinones, -dihydrodiols 
and -diolepoxides
29 
Knize et al. (2006) Isomeric series of heterocyclic amines (amino-
trimethylimidazopyridine (TMIP) isomers
11
Lanevskij et al. (2006) Diverse compounds 945 
Shoji et al. (2006) Diverse compounds (environmental pollutants) 82
Takamura-Enya et al. (2006) Aromatic nitro compounds - nitro derivatives of 
benzan-throne
9
Vracko (2006) Pyriminoizodiamine isomers and aromatic/
heteroaromatic amines
12 pyriminoizodiamines and 
95 aromatic/ heteroaromatic 
amines
Benigni et al. (2005) Alpha,beta-unsaturated aldehydes 26
Bhat et al. (2005) Derivatives of aromatic amines 181
Cash et al. (2005) Aromatic amines 29 
Cho (2005) Mutagen X  ( bi-product caused by this disinfection 
process) and analogues
37
Contrera et al. (2005) Pharmaceuticals and non-pharmaceuticals 3228
Crettaz et al. (2005) Pesticides 60
46
Reference Chemical classes Dataset size
Glowienke et al. (2005) Methane-, benzene- and toluene-sulfonic acid esters 19
Gonzalez et al. (2005) Dental monomers 53 
Hayashi et al. (2005) Diverse compounds 909
Jacobs (2005) Pharmaceuticals N/A
Kazius et al. (2005) Diverse compounds from CCRIS, Toxnet, NTP, 
CPDB and GAP
4872 
Mahe et al. (2005) 1) aromatic and hetero-aromatic nitro compounds
2) Diverse compounds from CPDB
1) 230
2) 684 
Mekenyan et al. (2005) Pesticide active ingredients 25
Tarasov et al. (2005) Diverse compounds from NTP, Gentox and GAP 105
Wang et al. (2005) Nitroaromatics 219
Xiao et al. (2005) Substituted benzenes compds 36
Andrews et al. (2004) N-acyloxy-N-alkoxyamide analogues 41
Bang et al. (2004) Mutagen X  and its analogs 29
Gonzalez et al. (2004) Dental monomers - cycloaliphatic epoxides 15 
Gonzalez et al. (2004) Dental monomers - aromatic epoxides 16 
Helguera et al. (2004) Dental monomers 23 
Helma et al. (2004) Diverse compounds from CPDB 684
Jezierska et al. (2004) Aromatic and heteroaromatic amines 95
Klopman et al. (2004) Organic compounds from the NTP and Gene-Tox 
databases
2513
Popelier et al. (2004) Heteroaromatic triazenes, halogenated 
hydroxyfuranones (Mutagen X  derivatives)
23/24
Rosenkranz (2004) Diverse compounds from the Zeiger genotoxicity 
database
300
Snyder et al. (2004) Pharmaceuticals 394
Valkova et al. (2004) Aromatic and heteroaromatic amines 95
Votano et al. (2004) Therapeutic drugs, diverse compounds from 
PHYSPROP, TOXNET, RTECS and drugs from 
the Physicians Desk Reference, version 6.0a (2003)
10,000
Votano et al. (2004) Diverse compounds from TOXMET, RTECS and 
drugs from the Physicians Desk Reference, version 
6.0a (2003)
336 
Vracko et al. (2004) Trimethylimidazopyridine isomers 12
Vracko et al. (2004) Aromatic amines 95
Basak et al. (2003) Neutral halocarbons 55
Benigni et al. (2003) Simple aldehydes and •-• unsaturated. aldehydes 21
Chen et al. (2003) Benzidine (BZ) and its six structural analogs 7
Cho (2003) Mutagen X (MX), 3-chloro-4-(dichloromethyl)-5-
hydroxy-2(5H)-furanone and its analaogs (open and 
ring form)
7
Gramatica et al. (2003) Aromatic amines 146
Halova et al. (2003) Aromatic and heteroaromatic nitro compounds N/A
He et al. (2003) Polycyclic aromatic compounds  (PACs) 277 
Klopman et al. (2003) High Production Volume Chemicals 2484
Lewis et al. (2003) Benzidine and amino-biphenyl analogues 11
Mattioni et al. (2003) Aromatic and secondary amine compounds 334 
McElroy et al. (2003) Diverse organic compounds from the NTP database 
and the Data Book of Chromosomal Aberration 
297
47
Reference Chemical classes Dataset size
Test In Vitro (Sofuni et al.)
Mosier et al. (2003) Thiophene derivatives N/A
Rosenkranz (2003) Diverse compounds (more detailed information not 
available)
10,000
Sztandera et al. (2003) Aminoazo derivatives and their reductive cleavage 
products
62 aminoazo, 12 cleavage 
products
White et al. (2003) Diverse compounds, drug candidates 94 diverse;,520 drugs
Bacha et al. (2002) Diverse compounds from TOXNET and GAP N/A
Garg et al. (2002) Aminoazobenzene derivatives 43
Ivanciuc (2002) Methylated and non-methylated polycyclic aromatic 
hydrocarbons (PAHs)
87 
Kauffman et al. (2002) Diverse secondary and aromatic amine compounds 256
Kubo et al. (2002) Diverse compounds 255
Livingstone et al. (2002) Diverse compounds from the literature 90 
Poletti et al. (2002) Cyclopentaphenanthrene derivatives 31
Roberts et al. (2002) Substituted naphthoquinones 29
Rosenkranz (2002) Diverse compounds from NTP and CPDB, as well 
as the Sigma, Aldrich, Lancaster Synthesis, Fluka 
catalogues
10,000
Toropov et al. (2002) Heteroaromatic amines 73 
Woo et al. (2002) Disinfection Byproducts N/A
Cash (2001) Aromatic and heteroaromatic 95
Rosenkranz et al. (2001) Diverse compounds 1500
Yourtee et al. (2001) Dental monomers 54
Janzowski et al. (2000) 2-alkenal food relevant compds 7
Karelson et al. (2000) Heteroaromatic and aromatic amines 95
Lozano et al. (2000) Heterocyclic amines 12
Baeten et al. (1999) Chlorinated hydrocarbons 10
Maran et al. (1999) Heteroaromatic and aromatic amines 95
Tuppurainen (1999) Halogenated hydroxyfuranones including MX 29
Zhu et al. (1999) Thalidomide, and its metabolites 131
CCRIS - Carcinogenesis Research Information System database; CPDB - Carcinogenic Potency Database; GAP- Genetic Activity Profile 
Database developed by US EPA; NTP – National Toxicology Progam database; PHYSPROP – SRC Physical Properties Database 
(http://srcinc.com/);  TOXNET - National Library of Medicine’s Toxicology Data Network
48
Table 8. Primary (Q)SAR studies on carcinogenicity published in the past 10 years
Reference Chemical classes Dataset size
Bercu et al. (2010) Diverse compounds from CPDB 694
Tanabe et al. (2010) Diverse compounds 911
Fjodorova et al. (2010) Diverse compounds from CPDB 805
Wang et al. (2009) Diverse compounds 693
Fjodorova et al. (2009) Diverse compounds 805
Massarelli et al. (2009) Diverse compounds from CPDB 55
Toropov et al. (2009) Diverse compounds from CPDB 401 
Venkatapathy et al. (2009) Diverse chemicals from CPDB 590
Bruce et al. (2008) Polycyclic aromatic hydrocarbons 23
Cunningham et al, (2008) Industrial chemicals 104
Fratev et al. (2008) Benzene derivatives 100
Helguera et al. (2008) Nitroso compounds 39
Helguera et al. (2008) Nitro compounds 55 
Helguera et al. (2008) Nitroso compounds 26
Matthews et al. (2008) Diverse compounds from FDA/CDER 
database 
1572
Mayer et al. (2008) Diverse compounds from CPDB 650 
Ruiz et al. (2008) Polychlorinated biphenyls 209
Vijayalakshmi et al. (2008) Polycyclic aromatic hydrocarbons 17
Zhu et al. (2008) Diverse compounds from NTP 384
Bull & Reckhow (2007) Haloquinones, halogenated furans and 
nitrosamines
21
Contrera et al. (2007) Diverse compounds, including marketed 
drugs and organic chemicals with 
pharmacologic properties, and non-
therapeutics that are pesticides or industrial 
chemicals.
1540
Deeb et al. (2007) Sulfa drugs 18
Fang et al. (2007) Aromatic and heteroaromatic amines 80
Fratev et al. (2007) Benzene derivatives 100 
Helguera et al. (2007) Nitroso compounds 35
Valerio et al. (2007) Small organic naturally occurring chemicals 
found in the human diet
120
Dhar et al. (2006) Benz[a]anthracenes and benz[c]acridine 14
Helguera et al. (2006) Nitro compounds 62 
Helguera et al. (2006) Nitro compounds (aromatic and aliphatic) 49
Helguera et al. (2006) Nitro compounds 188 
Helma (2006) Diverse compounds from CPDB 3985
Matthews et al. (2006a,b) Diverse compounds 1442 
Bailey et al. (2005) Food contact substances from RTECS, 
PAFA, CPDB 
N/A
49
Reference Chemical classes Dataset size
Chen et al. (2005) NCTR estrogen activity data set containing 
232 structurally diverse chemicals, and 
NCTR liver cancer database generated 
232 / 996
Contrera et al. (2005) Organic compounds 1072
Crettaz et al. (2005) Pesticides 60
Helguera et al. (2005) Diverse compounds from CPDB 189
Hemmateenejad et al. (2005) Drugs 735 
Lagunin et al. (2005) Diverse compounds from NTP and CPDB 1602
Rallo et al. (2005) Aromatic compounds containing nitrogen 
substituents
104
Suzuki (2005) Diverse compounds from NTP 323
Woo et al. (2005) New chemicals N/A
Benigni et al. (2003) Simple aldehydes and alpha-beta unsaturated 
aldehydes
8 / 21
Shen et al. (2003) Aromatic amines N/A
Toivonen et al. (2003) Diverse compounds from NTP and CPDB 2419
Marino et al. (2002) Methylated polycyclic aromatic 
hydrocarbons
49
Kabankin et al. (2001) Aromatic amines 38
Gallegos et al. (2001) Polycyclic aromatic hydrocarbons 78
CCRIS - Carcinogenesis Research Information System database; CPDB - Carcinogenic Potency Database; NCTR - National Center for 
Toxicological Research; NTP – National Toxicology Progamme database; PAFA – US FDA Priority-Based Assessment of Food 
Additives database
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